Literature DB >> 31156944

Does an interaction exist between ketamine hydrochloride and Becton Dickinson syringes?

M Closset1, J D Hecq2,3, E Gonzalez1,3, B Bihin3,4, J Jamart3,4, L Galanti1,3.   

Abstract

INTRODUCTION: An international alert from Becton Dickinson (BD) has noted the possibility of interaction between several molecules and some syringes. The Centralized IntraVenous Additives Service of the institution was using 3 mL BD syringes to store ketamine HCl. This study evaluated the interaction between ketamine and these syringes.
METHOD: A batch of BD syringes produced in Europe and left in quarantine from the day of the international alert has been tested at 22, 29, 36, 43 and 50 days of storage at room temperature. At each time, the pH of the solutions was measured. The solutions were inspected visually and by microscope, and spectrophotometric measurements were performed. The concentrations were measured by a validated ultra-high-performance liquid chromatography-diode array detector.
RESULTS: Neither physical change nor pH modification was observed during the study. According to a lower limit of the 95% unilateral CI on the mean >90% of the theoretical concentration, the solutions remain stable for at least 50 days.
CONCLUSION: In our study conditions, ketamine can be stored for at least 50 days without risk of sorption with syringes.

Entities:  

Keywords:  Spectrophotometry; UPLC; ketamine; pHmeter

Year:  2016        PMID: 31156944      PMCID: PMC6451573          DOI: 10.1136/ejhpharm-2016-001045

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  23 in total

1.  Stability of diluted ketamine packaged in glass vials.

Authors:  Ronald F Donnelly
Journal:  Can J Hosp Pharm       Date:  2013-05

2.  Recognition and identification of UV-absorbing leachables in EPREX pre-filled syringes: an unexpected occurrence at a formulation-component interface.

Authors:  James Pang; Tim Blanc; John Brown; Steven Labrenz; Annabelle Villalobos; Anneli Depaolis; Srinivas Gunturi; Steve Grossman; Peter Lisi; George A Heavner
Journal:  PDA J Pharm Sci Technol       Date:  2007 Nov-Dec

Review 3.  Centralized intravenous additive services (CIVAS): the state of the art in 2010.

Authors:  J-D Hecq
Journal:  Ann Pharm Fr       Date:  2010-12-30

4.  Drug shortages in Canadian anesthesia: a national survey.

Authors:  Richard Hall; Gregory L Bryson; Gordon Flowerdew; David Neilipovitz; Agnieszka Grabowski-Comeau; Alexis F Turgeon
Journal:  Can J Anaesth       Date:  2013-04-02       Impact factor: 5.063

Review 5.  Extractables and leachables considerations for prefilled syringes.

Authors:  Dennis R Jenke
Journal:  Expert Opin Drug Deliv       Date:  2014-06-23       Impact factor: 6.648

Review 6.  Drug shortages: a complex health care crisis.

Authors:  Erin R Fox; Burgunda V Sweet; Valerie Jensen
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

7.  Drug compatibility with new polyolefin infusion solution containers.

Authors:  Lawrence A Trissel; Quanyun A Xu; Mary Baker
Journal:  Am J Health Syst Pharm       Date:  2006-12-01       Impact factor: 2.637

8.  Mechanically-induced aggregation of the monoclonal antibody cetuximab.

Authors:  A Lahlou; B Blanchet; M Carvalho; M Paul; A Astier
Journal:  Ann Pharm Fr       Date:  2009-07-28

9.  Stability of Ketamine Hydrochloride Injection After Reconstitution in Water for Injection and Storagein 1-mL Tuberculin Polypropylene Syringes for Pediatric Use.

Authors:  Vishnu Das Gupta
Journal:  Int J Pharm Compd       Date:  2002 Jul-Aug

10.  A general strategy for the chemical aspects of the safety assessment of extractables and leachables in pharmaceutical drug products: the chemical assessment triad.

Authors:  Dennis Jenke
Journal:  PDA J Pharm Sci Technol       Date:  2012 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.